Breast Cancer

Breast Cancer
2024-12-04T05:37:42.078Z

DYNASTY-Breast-02

DYNASTY-Breast-02
Breast cancer

A Phase 3, Randomized, Multi-center, Open-label Study of DB-1303 Versus Investigator’s Choice Chemotherapy in Human Epidermal Growth Factor Receptor 2 (HER2)-low, Hormone Receptor Positive (HR+) Metastatic Breast Cancer Patients whose Disease has Progressed on Endocrine Therapy (ET) (DYNASTY-Breast02)

A Phase 3, Randomized, Multi-center, Open-label Study of DB-1303 Versus Investigator’s Choice Chemotherapy in Human Epidermal Growth Factor Receptor 2 (HER2)-low, Hormone Receptor Positive (HR+) Metastatic Breast Cancer Patients whose Disease has Progressed on Endocrine Therapy (ET) (DYNASTY-Breast02)

Trial overview

Clinical Area

Medical Oncology

Disease / Condition

Breast cancer

Study Phase

III

Trial Identifiers
GenesisCare Location(s)
St Andrew's Precinct (Oncology)
location pin icon

Level 1, 337 South Terrace, Adelaide, SA, 5000, Australia

phone icon (08) 8228 6700 email icon infooncologysa@genesiscare.com
SA
St Andrew's Precinct (Oncology)
Principal Investigator(s)
Medical Oncologist

A/Prof Nick Murray

BM MS MA DPhil FRCP(Lon) FRACP

A/Prof Nick Murray
location pin icon

St Andrew's Precinct (Oncology)

View Profile
Profile Image - A/Prof Nick  Murray

Thank you for submitting.

We will be in touch within 24 hours

An unexpected error has occurred.

You will need to complete the form again, sorry for the inconvenience.

How can we help?

If you have a medical emergency please call 000. If you have an urgent request and would like to speak to our staff, please contact one of our centres directly.

* Indicates a required field.